Abstract Details

Title Degradation of Endocannabinoids in Chronic Migraine and Medication Overuse Headache

Topic Headache/Other Pain Syndromes

Presentation(s) (-)

Poster/Presentation
Number 066

Objective

Background

Design/Methods

Results

Conclusions

Authors/Disclosures
Letizia Maria Cupini, MD (ASL RM2 Ospedale Sant'Eugenio UOC Neurologia)	No disclosure on file
Paola Sarchielli	No disclosure on file
Paolo Calabresi, MD (Clinica Neurologica)	Dr. Calabresi has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Abbvie, Bial, Bayer Schering, Biogen-Dompè, Biogen-Idec, Eisai, Lilly, Lundbeck, Lusofarmaco, Merck-Serono, Novartis, Sanofi-Genzyme, Teva, UCB Pharma, Zambon..
Venkatachalam Mangeshkumar, MD, FAAN (Neurology and Stroke Associates, PC)	No disclosure on file
	No disclosure on file
	No disclosure on file
	No disclosure on file
	No disclosure on file
	No disclosure on file

��ɫ����